Survodutide
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
Boehringer Ingelheim · Phase 2 · Completed · Enrollment 387
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| 0.6 mg BI 456906 | Obesity or overweight | 0.6 mg | 46 | Efficacy | n/r |
| Placebo group | Obesity or overweight | n/r | 46 | Efficacy | n/r |
| 2.4 mg BI456906 | Obesity or overweight | 2.4 mg | 46 | Efficacy | n/r |
| 3.6 mg BI 456906 | Obesity or overweight | 3.6 mg | 46 | Efficacy | n/r |
| 4.8 mg BI 456906 | Obesity or overweight | 4.8 mg | 46 | Efficacy | n/r |